YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Mallinckrodt to pay $1.6B to settle opioid claims

Posted online

Generic drug manufacturer Mallinckrodt Pharmaceuticals reached a tentative deal to settle opioid claims.

Through the deal, Mallinckrodt would pay a $1.6 billion settlement and enter its generics business into Chapter 11 bankruptcy.

The settlement comes amid thousands of lawsuits in a federal case that seeks to determine who should be held financially liable for the impact of the opioid crisis.

Read more from The Washington Post.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick

Coronavirus Coverage

SBJ compiles news on the respiratory virus outbreak.

Most Read